pembrolizumab,ramucirumab
merck,eli lilly
['keytruda', 'cyramza', 'lung', 'lcsm,(-blcsm)']
despite similar responses to treatment, patients with previously treated non-small cell lung cancer derived a better overall survival benefit from treatment with keytruda combined with cyramza than the usage of standard-of-care therapies. #asco22 #lcsm 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.